Clinical Trial Update: A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 141W94 alone or with Zidovudine and 3TC in HIV infections; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 141W94
• 3TC (Lamivudine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED